Scientists recently discovered why Ozempic doesn’t work for everyone—and genetics may be the reason.
GLP-1 style drugs like Ozempic and Vegovy have become gamechangers in the fight against type 2 diabetes and reducing body fat, but for a significant portion of the population, the drugs have proven less successful. Some surprising new science suggests that this may be attributed to specific resistance to GLP-1s. New Stanford Research Links Genetics